Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGN1W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,296
Award facts
- Contract value 100% obligated
- $11,296.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,296.26 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a medication used to treat cystic fibrosis. This competitively awarded, firm fixed-price contract was executed on January 22, 2026, with an ultimate completion date of January 23, 2026, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under a larger indefinite delivery contract vehicle.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The contract structure enables efficient fulfillment of federal medical procurement requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FGN1W?
SPE2DR26FGN1W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FGN1W worth?
The government has obligated $11,296 on SPE2DR26FGN1W.
Is contract SPE2DR26FGN1W an order under another contract?
Yes. SPE2DR26FGN1W is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGN1W competed?
The extent of competition for SPE2DR26FGN1W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award